Pharma

By Jeff Lagasse July 17, 2017
Abbott and Bigfoot Biomedical have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions.    Under the agreement, Abbott will supply glucose measurement sensors for all of Bigfoot's insulin delivery systems in the U.S. as the exclusive sensors for those systems...
By Jeff Lagasse July 17, 2017
Novo Nordisk and Glooko are working together to help people manage diabetes from their phones. The companies have partnered on the Cornerstones4Care Powered by Glooko, an app melding Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics know-how. The idea behind the app is to provide, for people with diabetes, a means of measuring...
By Jonah Comstock July 14, 2017
In Q2 2017, we continued to see more pharma companies step up their efforts in digital health, from app launches to FDA clearances to wearable usage in clinical trials. Read on below for a summary of those moves. In a move that could have growing significance for pharma going forward, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics...
By Heather Mack July 11, 2017
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier. Palo Alto-based monARC Bionetworks is one of the latest to make...
By Heather Mack June 30, 2017
The relationship between global pharmaceutical company Roche and digital diabetes management app maker mySugr has been growing for the past couple of years. First there was the investment, then there was the partnership, and now Roche is going all in and becoming the exclusive shareholder of mySugr.  Under the agreement, mySugr will continue to function as a separate legal entity, but will serve...
By Heather Mack June 29, 2017
Life sciences consulting firm Parexel is teaming up with Sanofi to research the role of wearables in clinical trials. While sensor-enabled devices have increasingly featured in a variety of research projects and studies, their efficacy and accuracy remains a point of debate, and Parexel and Sanofi hope to investigate that question. Together, Sanofi and Parexel are leveraging their respective...
By Jonah Comstock June 28, 2017
Baltimore-based emocha Mobile Health has been awarded a $1.7 million Fast Track Small Business Innovation Research award by the National Institute on Drug Abuse (NIDA). The company will use the grant for a feasibility study of its digital direct observation therapy tech. Emocha is an acronym for “electronic mobile comprehensive health application”. The company has been developing an app for...
By Jonah Comstock June 26, 2017
The Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics, and regulators, including FDA, looking to create a new “gold standard” of clinical trial design using digital technology, released new endpoint recommendations today focused on the use of mobile technology in clinical trials.  “By engaging with experts who have been early champions...
By Jonah Comstock June 21, 2017
Madison, Wisconsin-based Propeller Health is now a decade old. The digital health company, which makes connected inhalers and patient- and provider-facing data analytics tools for respiratory diseases asthma and COPD, can hardly be considered a startup anymore. Nowadays the company has numerous published efficacy studies and business relationships with most major pharma companies in the...
By Jonah Comstock June 16, 2017
Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector and the app, due out in July, is myBetaApp. The Whippany, New Jersey-based pharma company didn't clear the app and device through the 510(k) medical device pathway; instead the agency approved a...